Table 2.
Comparisons of baseline characteristics according to median level of baseline NET in MHD patients.
| Baseline NET (median 7767.6) | ||||
|---|---|---|---|---|
| Variables | Total | <median level | ≥median level | p |
| Age (years) | 64.0 ± 13.0 | 62.4 ± 13.2 | 65.5 ± 13.0 | 0.35 |
| Gender, male, n (%) | 35 (58.3) | 18 (62.1) | 17 (54.8) | 0.38 |
| BMI | 22.9 ± 4.4 | 22.6 ± 4.2 | 23.2 ± 4.6 | 0.61 |
| Diabetes | 35 (58.3) | 17 (58.6) | 18 (58.1) | 0.59 |
| Duration of dialysis (months) | 49.4 ± 26.6 | 54.1 ± 25.2 | 41.9 ± 28.4 | 0.22 |
| Systolic blood pressure (mmHg) | 145.0 ± 19.8 | 141.9 ± 20.4 | 148.0 ± 19.4 | 0.24 |
| Diastolic blood pressure (mmHg) | 81.3 ± 10.7 | 79.0 ± 8.6 | 83.4 ± 12.2 | 0.11 |
| Previous CAD, n (%) | 19 (31.7) | 4 (13.8) | 15 (48.4) | 0.004 |
| Previous cerebrovascular accident, n (%) | 9 (15.0) | 2 (6.9) | 7 (22.6) | 0.08 |
| WBC count (/μL) | 6180 ± 1807 | 5622 ± 1896 | 6700 ± 1578 | 0.02 |
| Neutrophil count (/μL) | 4374 ± 1694 | 3482 ± 994 | 5302 ± 1777 | <0.001 |
| Lymphocyte count (/μL) | 1271 ± 479 | 1370 ± 479 | 1168 ± 460 | 0.13 |
| N/L ratio | 4.2 ± 3.0 | 2.7 ± 0.9 | 5.8 ± 4.4 | 0.001 |
| Hemoglobin (g/dL) | 10.3 ± 0.9 | 10.5 ± 0.9 | 10.2 ± 0.9 | 0.14 |
| Urea nitrogen (mg/dL) | 52.6 ± 20.4 | 55.1 ± 22.3 | 50.3 ± 18.5 | 0.36 |
| Creatinine (mg/dL) | 8.2 ± 3.4 | 8.9 ± 3.5 | 7.6 ± 3.1 | 0.17 |
| Albumin (g/dL) | 3.6 ± 0.5 | 3.6 ± 0.6 | 3.6 ± 0.5 | 0.76 |
| Uric acid (mg/dL) | 6.9 ± 1.6 | 6.9 ± 1.9 | 6.8 ± 1.4 | 0.86 |
| Cholesterol (mg/dL) | 139.0 ± 28.7 | 145.9 ± 29.2 | 132.6 ± 27.7 | 0.07 |
| hs-CRP (mg/L)∗ | 0.40 ± 1.13 | 0.03 ± 0.94 | 0.75 ± 1.20 | 0.01 |
| Intact PTH (pg/mL) | 181.5 ± 149.2 | 201.0 ± 158.8 | 163.1 ± 139.6 | 0.33 |
| β2-microglobulin | 22.9 ± 8.4 | 20.6 ± 5.8 | 25.7 ± 10.2 | 0.06 |
| spKt/V | 1.60 ± 0.28 | 1.57 ± 0.23 | 1.64 ± 0.33 | 0.42 |
| Medications, % | ||||
| Aspirin | 56.8% | 59.1% | 55.5% | 0.78 |
| Lipid-lowering agent | 35.0% | 33.3% | 37.1% | 0.44 |
All data are expressed as mean ± SD except for those with ∗ which are expressed as median with range.
BDI-II: Beck depression inventory II; BMI: body mass index; ESRD: end-stage renal disease; intact PTH: intact parathyroid hormone; TSH: thyroid-stimulating hormone; hs-CRP: high-sensitivity C-reactive protein; spKt/V: single pool Kt/V; nPCR: normalized protein catabolism rate.